Literature DB >> 18020948

SARS-CoV accessory protein 7a directly interacts with human LFA-1.

Karen Hänel1, Dieter Willbold.   

Abstract

The SARS-CoV accessory protein 7a is a type I membrane protein with an extracellular domain of 81 amino acid residues. It is described to be expressed during infection and to be a component of the virus particle surface. In this study, we demonstrate that protein 7a binds directly and specifically to human lymphocyte function-associated antigen 1 (LFA-1) on the cell surface of Jurkat cells. The binding is increased upon artificial cell activation with phorbol ester. These observations are confirmed by direct in vitro binding of recombinant protein 7a to the wild type and mutant K287C/K294C I domain showing that the I domain is the 7a binding site in the alpha(L) chain of LFA-1. Consequences of the LFA-1 interaction with 7a are discussed. In particular, our data suggest LFA-1 to be an attachment factor or the receptor for SARS-CoV on human leukocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18020948     DOI: 10.1515/BC.2007.157

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  10 in total

1.  SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5.

Authors:  Uddhav Timilsina; Supawadee Umthong; Emily B Ivey; Brandon Waxman; Spyridon Stavrou
Journal:  Nat Commun       Date:  2022-05-26       Impact factor: 17.694

2.  Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach.

Authors:  Marie-Thérèse Hopp; Daniel Domingo-Fernández; Yojana Gadiya; Milena S Detzel; Regina Graf; Benjamin F Schmalohr; Alpha T Kodamullil; Diana Imhof; Martin Hofmann-Apitius
Journal:  Biomolecules       Date:  2021-04-27

Review 3.  A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host.

Authors:  Rinki Minakshi; Arif Tasleem Jan; Safikur Rahman; Jihoe Kim
Journal:  Front Cell Infect Microbiol       Date:  2020-10-16       Impact factor: 5.293

4.  In silico comparative genomics of SARS-CoV-2 to determine the source and diversity of the pathogen in Bangladesh.

Authors:  Tushar Ahmed Shishir; Iftekhar Bin Naser; Shah M Faruque
Journal:  PLoS One       Date:  2021-01-20       Impact factor: 3.240

5.  Gene variants of coagulation related proteins that interact with SARS-CoV-2.

Authors:  David Holcomb; Aikaterini Alexaki; Nancy Hernandez; Ryan Hunt; Kyle Laurie; Jacob Kames; Nobuko Hamasaki-Katagiri; Anton A Komar; Michael DiCuccio; Chava Kimchi-Sarfaty
Journal:  PLoS Comput Biol       Date:  2021-03-17       Impact factor: 4.475

6.  Phage Display-Derived Compounds Displace hACE2 from Its Complex with SARS-CoV-2 Spike Protein.

Authors:  Marc Sevenich; Elena Thul; Nils-Alexander Lakomek; Thomas Klünemann; Maren Schubert; Federico Bertoglio; Joop van den Heuvel; Patrick Petzsch; Jeannine Mohrlüder; Dieter Willbold
Journal:  Biomedicines       Date:  2022-02-14

Review 7.  The role of severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesis.

Authors:  Ruth McBride; Burtram C Fielding
Journal:  Viruses       Date:  2012-11-07       Impact factor: 5.048

Review 8.  Accessory proteins of SARS-CoV and other coronaviruses.

Authors:  Ding Xiang Liu; To Sing Fung; Kelvin Kian-Long Chong; Aditi Shukla; Rolf Hilgenfeld
Journal:  Antiviral Res       Date:  2014-07-01       Impact factor: 5.970

9.  Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes.

Authors:  Ziliang Zhou; Chunliu Huang; Zhechong Zhou; Zhaoxia Huang; Lili Su; Sisi Kang; Xiaoxue Chen; Qiuyue Chen; Suhua He; Xia Rong; Fei Xiao; Jun Chen; Shoudeng Chen
Journal:  iScience       Date:  2021-02-12

10.  ACE2-independent infection of T lymphocytes by SARS-CoV-2.

Authors:  Xu-Rui Shen; Rong Geng; Qian Li; Ying Chen; Shu-Fen Li; Qi Wang; Juan Min; Yong Yang; Bei Li; Ren-Di Jiang; Xi Wang; Xiao-Shuang Zheng; Yan Zhu; Jing-Kun Jia; Xing-Lou Yang; Mei-Qin Liu; Qian-Chun Gong; Yu-Lan Zhang; Zhen-Qiong Guan; Hui-Ling Li; Zhen-Hua Zheng; Zheng-Li Shi; Hui-Lan Zhang; Ke Peng; Peng Zhou
Journal:  Signal Transduct Target Ther       Date:  2022-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.